Anti-HER2 and anti-IGF-IR BI-specific antibodies and uses thereof
US-9481729-B2 · Nov 1, 2016 · US
Assays involving growth factors
Assays involving growth factors · Cooperative Patent Classification (CPC)
Computing, optics, measurement, and control technologies.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | G01N2333/475 |
| Official title | Assays involving growth factors |
| Display label | Assays involving growth factors |
| Total patents | 304 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is declining.
| Year | Patents |
|---|---|
| 2015 | 47 |
| 2016 | 28 |
| 2017 | 36 |
| 2018 | 29 |
| 2019 | 28 |
| 2020 | 25 |
| 2021 | 29 |
| 2022 | 27 |
| 2023 | 16 |
| 2024 | 13 |
| 2025 | 22 |
| 2026 | 4 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Targeting gdf6 and bmp signaling for anti-melanoma therapy
US-2016279207-A1 · Sep 29, 2016 · US
Modular point-of-care devices, systems, and uses thereof
US-2016266108-A1 · Sep 15, 2016 · US
Stem cell factor inhibitor
US-2016251423-A1 · Sep 1, 2016 · US
Modular point-of-care devices, systems, and uses thereof
US-2016161513-A1 · Jun 9, 2016 · US
Novel dual-targeting protein binding specifically to dll4 and vegf and use thereof
US-2016159929-A1 · Jun 9, 2016 · US
Stem cell factor inhibitor
US-9353178-B2 · May 31, 2016 · US
Reagents for reducing leukocyte interference in immunoassays
US-9316638-B2 · Apr 19, 2016 · US
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
US-2016097779-A1 · Apr 7, 2016 · US
Modular point-of-care devices, systems, and uses thereof
US-9285366-B2 · Mar 15, 2016 · US
Elisa for vegf
US-2016033517-A1 · Feb 4, 2016 · US
Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues
US-9249388-B2 · Feb 2, 2016 · US
Modular point-of-care devices, systems, and uses thereof
US-2016025721-A1 · Jan 28, 2016 · US
Biomarkers and methods for measuring and monitoring inflammatory disease activity
US-2015377909-A1 · Dec 31, 2015 · US
Modular point-of-care devices, systems, and uses thereof
US-2015377871-A1 · Dec 31, 2015 · US
Use of IGF-1 as a Reagent for Early Diagnosis and/or Prognosis of Alzheimer Disease
US-2015374852-A1 · Dec 31, 2015 · US
Modular point-of-care devices, systems, and uses thereof
US-2015377914-A1 · Dec 31, 2015 · US
Vascular endothelial growth factor-binding aptamers
US-2015376620-A1 · Dec 31, 2015 · US
Modular point-of-care devices, systems, and uses thereof
US-2015355169-A1 · Dec 10, 2015 · US
Biomarkers and methods for measuring and monitoring inflammatory disease activity
US-9200324-B2 · Dec 1, 2015 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC G01N2333/475?
- CPC G01N2333/475 is the Cooperative Patent Classification code for “Assays involving growth factors.”
- How many patents are filed under CPC G01N2333/475 (Assays involving growth factors)?
- Our database includes 304 publications tagged with this CPC code.
- Is patent activity under CPC G01N2333/475 growing?
- Publication counts under this code: 13 in 2024 vs 22 in 2025 (latest complete years).